Triamcinolone Levels in Cochlear Perilymph - Trial NCT03248856
Access comprehensive clinical trial information for NCT03248856 through Pure Global AI's free database. This Phase 1 trial is sponsored by Christoph Arnoldner and is currently Completed. The study focuses on Cochlear Hearing Loss. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Christoph Arnoldner
Medical University of Vienna
Timeline & Enrollment
Phase 1
Oct 02, 2017
May 31, 2021
Primary Outcome
Triamcinolone levels in comparison
Summary
In this study Triamcinolone acetonide will be applied intratympanically before cochlear
 implant surgery. After round window exposure, a perilymph sample and simultaneously a blood
 sample will be drawn. Triamcinolone levels will then be analyzed in the samples.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03248856
Non-Device Trial